5. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2024. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 13, 2024.
- Amphetamine mixed salts tablets (Adderall) package insert. Teva Pharmaceuticals USA, Inc., May 2024.
- Amphetamine mixed salts extended-release capsules (Adderall XR) package insert. Takeda Pharmaceuticals America, Inc., October 2023.
- Amphetamine mixed salts extended-release capsules (Mydayis) package insert. Takeda Pharmaceuticals America, Inc., October 2023.
- Amphetamine extended-release orally disintegrating tablets (Adzenys XR-ODT) package insert. Neos Therapeutics, Inc., March 2024.
- Amphetamine extended-release oral suspension (Dyanavel XR) package insert. Nextwave Pharmaceuticals, Inc., October 2023.
- Dexmethylphenidate tablets (Focalin) package insert. Novartis Pharmaceuticals Corp., October 2023.
- Dexmethylphenidate extended-release capsules (Focalin XR) package insert. Novartis Pharmaceuticals Corp., October 2023.
- Dextroamphetamine transdermal system (Xelstrym) package insert. Noven Therapeutics, LLC., October 2023.
- Lisdexamfetamine capsule and chewable tablets (Vyvanse) package insert. Takeda Pharmaceuticals America, Inc., October 2023.
- Methylphenidate extended-release capsules (Aptensio XR) package insert. Rhodes Pharmaceuticals, April 2024.
- Methylphenidate extended-release tablets (Concerta) package insert. Janssen Pharmaceuticals, Inc., October 2023.
- Methylphenidate extended-release capsules (Jornay PM) package insert. Ironshore Pharmaceuticals, Inc., October 2023.
- Methylphenidate extended-release capsules (Metadate CD) package insert. Aytu BioPharma, Inc., October 2023.
- Methylphenidate extended-release tablets package insert. KVK-Tech, Inc., June 2024.
- Methylphenidate oral solution (Methylin) package insert. Shionogi Pharma, Inc., October 2023.
- Methylphenidate chewable tablets package insert. Camber Pharmaceuticals, Inc., September 2023.
- Methylphenidate extended-release tablets (Relexxii) package insert. Vertical Pharmaceuticals, LLC. May 2024.
- Methylphenidate tablets (Ritalin) package insert. Novartis Pharmaceuticals Corp., October 2023.
- Methylphenidate extended-release capsules (Ritalin LA) package insert. Novartis Pharmaceuticals Corp., October 2023.
- Methylphenidate tablets, extended-release tablets package insert. Mayne Pharma., February 2023.
- Methylphenidate extended-release chewable tablets (QuilliChew XR) package insert. NextWave Pharmaceuticals, Inc. October 2023.
- Methylphenidate extended-release oral suspension (Quillivant XR) package insert. NextWave Pharmaceuticals, Inc. October 2023.
- Serdexmethylphenidate and dexmethylphenidate capsules (Azstarys) package insert. Corium, Inc., October 2023.
- Atomoxetine (Strattera) capsules package insert. Eli Lilly and Company, January 2022.
- Viloxazine extended-release capsules (Qelbree) package insert. Supernus Pharmaceuticals, Inc., December 2023.
- Guanfacine extended-release tablets (Intuniv) package insert. Takeda Pharmaceuticals America Inc., December 2022.
- Texas Health and Human Services. Psychotropic medication utilization parameters for children and youth in Texas Public Behavioral Health (7th version). July 2023. Accessed September 17, 2024. Available at: hhs.texas.gov/sites/default/files/documents/psychotropic-medication-utilization-parameters-medication-tables.pdf
- Amphetamine sulfate tablets (Evekeo) package insert. Azurity Pharmaceuticals, Inc., October 2023.
- Dextroamphetamine tablets package insert. Teva Pharmaceuticals USA, Inc., September 2023.
- Dextroamphetamine extended-release capsules (Dexedrine Spansule) package insert. Amneal Pharmaceuticals, LLC., October 2023.
- Dextroamphetamine oral solution (ProCentra) package insert. Independence Pharmaceuticals, September 2023.
- Dextroamphetamine tablets (Zenzedi) package insert. Azurity Pharmaceuticals, Inc., November 2023.
- Methamphetamine tablets package insert. Hikma Pharmaceuticals USA., Inc., November 2023.
- Methylphenidate extended-release orally disintegrating tablets (Cotempla XR-ODT) package insert. Neos Therapeutics, Inc., March 2024.
- Methylphenidate transdermal system (Daytrana) package insert. Noven Pharmaceuticals, April 2024.
- Clonidine extended-release tablets package insert. Actavis Pharma, Inc., October 2023.
- Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed., American Psychiatric Association, 2022.
- Wolraich ML, Hagan JF, Allan C, et. al. Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder; clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. October 2019; 144 (4): e20192528. 10.1542/peds.2019-2528.